Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HOXA9 inhibitors(homeobox A9 inhibitors), MEIS1 inhibitors(Meis homeobox 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H16N2O5S |
InChIKeyKGSKTLMBOLPOTC-UHFFFAOYSA-N |
CAS Registry939228-52-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Preclinical | AU | 14 Jun 2016 |